Voters to Decide on $7.4 Billion Research Bond

California's Senate Bill 895 and Proposition 38 would fund biomedical and immunology research after federal grant cuts.

Updated on Nov. 2, 2026 in Biotech

Bold flat-color editorial illustration of a single amber glass flask on a plinth with a distant coastal hill, in deep red and cream, evoking state-funded research.
California voters will decide on Senate Bill 895 and Proposition 38, which together would authorize roughly $15.8 billion in research bonds to offset federal grant cuts. AI Illustration. Upload story photo >

Live Poll

Should California borrow billions to fund research that federal cuts have reduced?

California voters will decide on Senate Bill 895 in the March 2028 primary election, a measure that would authorize $7.4 billion in bonds for biomedical, behavioral science, and climate health research. Proposition 38, which will appear on the 2026 midterm ballot, sets a separate $8.4 billion bond for immunology research.

Why it matters

The measures follow the Trump administration's cancellation of roughly $3 billion in scientific research grants in 2025 and the NIH's shutdown of its social sciences division. California is using state funding to fill gaps left by federal cuts to research.

Proposition 38 directs $4.2 billion, half its total, to the California Institute for Immunology and Immunotherapy, and would borrow from the California General Fund. The UCs received about $5 billion from the General Fund for the 2026-27 academic year, and how the new bonds would be divided among campuses is not yet settled.

The players

Gary Michelson

Co-founder of the California Institute for Immunology and Immunotherapy and biggest financial contributor to Proposition 38.

California Institute for Immunology and Immunotherapy

Institution that would receive half of Proposition 38's bond funds for immunology research.

The details

Senate Bill 895 passed unanimously in the Senate in August and would establish the California Foundation for Science and Health Research to award grants statewide. Proposition 38 was introduced by Gary Michelson, who co-founded the California Institute for Immunology and Immunotherapy and is the measure's largest financial contributor.

Timeline

  1. 2025: Federal cuts canceled roughly $3 billion in research grants.

  2. August 2026: SB 895 passed unanimously in the state Senate.

  3. 2026 midterm elections: Proposition 38 appears on the ballot.

  4. March 2028: California primary election, when voters decide on SB 895.

Roadmap

California's proposed bonds are a direct state response to the 2025 cancellation of roughly $3 billion in federal scientific research grants and the NIH's sharp reduction in new awards. Federal budget proposals for fiscal year 2027 include further NIH and NSF cuts, which would widen the funding gap the state is attempting to fill.

If approved, the bonds would fund grants for biomedical, behavioral, and immunology research across California, potentially affecting research institutions and the types of studies conducted in the state. Voters will have the final say on both measures at the ballot box.

The takeaway

The outcome of these measures will determine whether California can sustain research funding independently of federal budget decisions. Readers following state ballot initiatives can track both measures as they move toward their respective election dates.

What happens next

Proposition 38 will appear on the 2026 midterm ballot, and SB 895 will be decided by voters in the March 2028 primary election.

Further reading

Explore more Biotech developments shaping California's research funding landscape.

Source note: This article includes information reported by City on a Hill Press.

Live Poll

Should California borrow billions to fund research that federal cuts have reduced?